Philips recalls some previously replaced ventilators: FDA statement

Philips, the medical devices company that has been struggling with a major recall of ventilators, is recalling some of the machines it has previously replaced, according to an FDA statement.

Asthma is a highly variable disease with different endotypes, or mechanisms of action, that respond differently to various treatments, study leader Dr Juan Celedon of UPMC Children’s Hospital of Pittsburgh said in a statement.
Asthma is a highly variable disease with different endotypes, or mechanisms of action, that respond differently to various treatments, study leader Dr Juan Celedon of UPMC Children’s Hospital of Pittsburgh said in a statement. (Supplied)

Philips, the medical devices company that has been struggling with a major recall of ventilators, is recalling some of the machines it has previously replaced, according to an FDA statement.

Philips could not immediately be reached for comment on Monday. The FDA said the company had notified it that the sound abatement foam could come loose in some refurbished models, "lowing the inspiratory pressure."

It was not clear how many of the replaced models could be affected.

Philips has replaced more than 4-million ventilators and sleep apnoea machines over the past 18 months due to worries that foam used in the machines could become toxic.

Reuters


Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Comment icon